Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say
By Svea Herbst-Bayliss NEW YORK (Reuters) -Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein (NASDAQ:HSIC) to refresh its board, cut costs, tackle succession planning and consider…
